论文部分内容阅读
将132例病人随机分为两组,治疗组68例给予依帕司他50mg,3次/d,前列地尔注射液10μg加入生理盐水250ml静脉滴注,1次/d;对照组64例单用前列地尔注射液10μg加入生理盐水250 ml静脉滴注,1次/d,均4周为1疗程,1个疗程后分别统计疗效。结果:治疗组总有效率为92.14%,对照组为82.81%,两组比较有显著差异(P<0.05)。结论:依帕司他联合前列地尔注射液治疗糖尿病周围神经病变疗效显著。
132 patients were randomly divided into two groups, the treatment group of 68 patients given epalrestat 50mg, 3 times / d, alprostadil 10μg saline 250ml intravenous infusion, 1 / d; the control group of 64 cases With alprostadil 10μg added saline 250 ml intravenous infusion, 1 / d, were 4 weeks for a course of treatment, a course of treatment were statistically effective. Results: The total effective rate was 92.14% in the treatment group and 82.81% in the control group, with significant difference between the two groups (P <0.05). Conclusion: Epalrestat plus alprostadil injection has significant therapeutic effect on diabetic peripheral neuropathy.